SOX2 and prostate cancer: Over-expression of Sox2 in human breast cell line-MDA231 and human prostate cancer cell line DU145 causes enhanced migration capacity and decreased levels of E-cadherin, DKK3 and increased a-SMA, DVL1 and DVL3.